Pharmacologic Management of Asthma - N1858

$17.95

About Course #N1858

Release Date: January 2, 2018

Expiration Date: January 31, 2021

Asthma medicines are used to prevent and control symptoms, to reduce the frequency and severity of acute attacks, and to reverse acute airflow obstruction. Asthma medicines are grouped into two general classes: quick-relief (rescue) and long-term control. Asthma therapy should match the severity of asthma symptoms. Persons classified as having intermittent asthma who are experiencing mild symptoms and those with exercise-induced asthma should be treated with quick-relief medication on an as-needed basis. Those with persistent symptoms should additionally receive a long-term controller medication or medications (intended to be used daily) for asthma control.

Although asthma is a lifelong disease with no cure, it can be controlled. This course focuses on general pharmacologic interventions for managing asthma as recommended by National Asthma Education Prevention Program (NAEPP) released the Expert Panel Report 3 (EPR3): Guidelines for the Diagnosis and Management of Asthma - Full Report 2007 (NHBLI, 2007) and the Global Initiative for Asthma (GINA) guidelines (2017), which are considered the "gold standard" for treating and managing asthma.

This course is an extract of, and should not be taken with, course #N1787 - Asthma Management in Children and Adults, 2nd Edition.

About the Author

Judith Quaranta, PhD, RN, CPN, AE-C, FNAP, is an Assistant Professor in the Decker School of Nursing, Binghamton University. She received her PhD from the Decker School of Nursing, with her dissertation focusing on asthma management of school nurses. Dr. Quaranta's research focus is on barriers and facilitators for asthma management. As a Train the Trainer for the American Lung Association's Open Airways for Schools curriculum, she has worked collaboratively with the Broome County Health Department, the Asthma Coalition of the Southern Tier, United Health Services Hospital, and the local American Lung Association to implement this program in local schools.

Course Disclosures

  • Courses must be completed on or before the expiration date noted in the course description above.
  • You must score 75% or higher on the final exam and complete the course evaluation to pass this course and receive a certificate of completion.
  • Through our review processes, Western Schools ensures that this course content is presented in a balanced, unbiased manner and is free from commercial influence. It is Western Schools' policy not to accept commercial support.
  • All persons involved in the planning and development of this course have disclosed no relevant financial relationships or other conflicts of interest related to the course content.

  • bvseo_sdk, p_sdk, 3.2.0
  • CLOUD, getContent, 28.06ms
  • REVIEWS, PRODUCT
  • bvseo-msg: HTTP status code of 404 was returned;